Benjamin Halladay

Insider Reports History

Location
Ann Arbor, MI
Signature
/s/ Sheldon L. Koenig, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Benjamin Halladay:

Company Role Class Num Shares Value Price $ Report Date Ownership
Esperion Therapeutics, Inc. Chief Financial Officer Common Stock 467,525 $1,714,414 $3.67 17 Dec 2025 Direct
Esperion Therapeutics, Inc. Chief Financial Officer Stock Option (right to buy) 213,000 $345,060 $1.62 14 Mar 2025 Direct

Insider Reports Filed by Benjamin Halladay

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ESPR Esperion Therapeutics, Inc. 17 Dec 2025 1 -$26,905 4 Chief Financial Officer 18 Dec 2025, 16:09
ESPR Esperion Therapeutics, Inc. 17 Sep 2025 1 -$19,785 4 Chief Financial Officer 18 Sep 2025, 16:06
ESPR Esperion Therapeutics, Inc. 17 Jul 2025 1 -$12.26 4 Chief Financial Officer 18 Jul 2025, 16:05
ESPR Esperion Therapeutics, Inc. 17 Jun 2025 1 -$8,328 4 Chief Financial Officer 18 Jun 2025, 18:44
ESPR Esperion Therapeutics, Inc. 17 Apr 2025 1 -$7.71 4 Chief Financial Officer 21 Apr 2025, 16:03
ESPR Esperion Therapeutics, Inc. 18 Mar 2025 1 -$5,242 4 Chief Financial Officer 19 Mar 2025, 16:03
ESPR Esperion Therapeutics, Inc. 14 Mar 2025 2 $0 4 Chief Financial Officer 17 Mar 2025, 17:16
ESPR Esperion Therapeutics, Inc. 19 Feb 2025 1 -$20.46 4 Chief Financial Officer 20 Feb 2025, 16:50
ESPR Esperion Therapeutics, Inc. 17 Jan 2025 1 -$20.38 4 Chief Financial Officer 21 Jan 2025, 16:38
ESPR Esperion Therapeutics, Inc. 17 Dec 2024 1 -$7,866 4 Chief Financial Officer 18 Dec 2024, 16:14
ESPR Esperion Therapeutics, Inc. 14 Mar 2024 2 $0 4 Chief Financial Officer 15 Mar 2024, 16:32
ESPR Esperion Therapeutics, Inc. 14 Mar 2023 2 $0 4 Chief Financial Officer 15 Mar 2023, 09:21
ESPR Esperion Therapeutics, Inc. 09 Dec 2022 2 $0 4 Chief Financial Officer 12 Dec 2022, 15:07
ESPR Esperion Therapeutics, Inc. 16 Nov 2022 0 $0 3 Chief Financial Officer 16 Nov 2022, 15:11